These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36965979)

  • 1. The road to hepatitis C virus elimination.
    Cotte L; Pradat P
    Lancet Public Health; 2023 Apr; 8(4):e254. PubMed ID: 36965979
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus in sub-Saharan Africa: a long road to elimination.
    Shah R; Agyei-Nkansah A; Alikah F; Asamoah-Akuoko L; Bagou YCO; Dhiblawe A; Ehichioya D; Finch PJ; Katsidzira L; Kodjoh N; Kpossou RA; Lakoh S; Makuza JD; Marowa L; Ndububa DA; Mbendi CN; Nyirenda M; Ocama P; Opio CK; Seremba E; Shindano TA; Thomson EC;
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):693-694. PubMed ID: 34391525
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries.
    Razavi H
    J Viral Hepat; 2021 Feb; 28(2):445. PubMed ID: 33205589
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a hepatitis C elimination program at a large academic health system.
    Tang R; Boike J; Patel S
    Liver Int; 2023 Sep; 43(9):2042-2043. PubMed ID: 37435687
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?
    Niebel M; Singer JB; Nickbakhsh S; Gifford RJ; Thomson EC
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):700-701. PubMed ID: 28895545
    [No Abstract]   [Full Text] [Related]  

  • 7. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for the Elimination of Hepatitis C in Cantabria.
    Crespo J; Tejerina Puente A; Cuadrado A; Llerena S; Cabezas J;
    Rev Esp Enferm Dig; 2020 Jul; 112(7):565-570. PubMed ID: 32543873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
    van Dijk M; Drenth JPH;
    J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral hepatitis C pandemic: Challenges and threats to its elimination.
    Krekulova L; Honzák R; Riley LW
    J Viral Hepat; 2021 May; 28(5):694-698. PubMed ID: 33550694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example.
    Altraif I
    Saudi Med J; 2018 Aug; 39(8):842-845. PubMed ID: 30106425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-elimination of hepatitis C virus infection - the beginning of the end.
    Huiban L; Stanciu C; Sfarti C; Muzica C; Cuciureanu T; Zenovia S; Frunzuc G; Damian I; Trifan A
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):688. PubMed ID: 33331344
    [No Abstract]   [Full Text] [Related]  

  • 13. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C elimination in Africa: Seizing the moment for hepatitis-C free future.
    Cordie A; Mohamed R; Sonderup MW; Wendy Spearman C; Medhat MA; Debzi N; Desalegn H; Esmat G
    Arab J Gastroenterol; 2021 Sep; 22(3):249-251. PubMed ID: 34531133
    [No Abstract]   [Full Text] [Related]  

  • 15. Poor linkage to care may compromise the Brazilian plan for hepatitis C elimination.
    Bittencourt PL; do Socorro Ferreira Iasi M; Viana MV; Crespo DM; Emerim E; de Almeida Borges PS; de Andrade ARC; Codes L; Ferraz MLG
    J Viral Hepat; 2023 Feb; 30(2):176-178. PubMed ID: 36302169
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus elimination: laying the foundation for achieving 2030 targets.
    Dore GJ; Bajis S
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):91-92. PubMed ID: 33257831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of pre-liver transplantation anti-hepatitis C virus treatment with direct-acting agent sofosbuvir.
    Borentain P; Colson P; Darque A; Gérolami R
    Liver Int; 2015 Jun; 35(6):1776. PubMed ID: 25619265
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C elimination among drug users in China: challenges, strategies and experiences].
    Wu T; Lin F; Wang J; Li H; Liu M; Zhang YR; Wang WW; Huang F
    Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):1002-1006. PubMed ID: 36299198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.
    Clement ME; Collins LF; Wilder JM; Mugavero M; Barker T; Naggie S
    Infect Dis Clin North Am; 2018 Jun; 32(2):407-423. PubMed ID: 29778263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.